CMR Surgical receives U.S. FDA Marketing Authorization for next-generation Versius Surgical System
15. Oktober 2024 07:00 ET
|
CMR Surgical
Versius granted marketing authorization through FDA’s De Novo process which establishes initial indication for adults undergoing cholecystectomyGlobally, Versius is the second most utilized surgical...